According to a new report jointly released today by WHO.

Despite certain limitations, the data constitute the best and most up-to-date estimates of the various elements of the ongoing health sector response to HIV/AIDS. For further information please contact: In Geneva: WHO Patricia Leidl Telephone: +41 22 791 5876 Mobile: +41 79 619 8525 E-mail: UNAIDS Sophie Barton-Knott Telephone: +41 22 791 1697 E-mail: In New York: UNICEF Najwa Mekki Phone: +1 212 326 7162 E-mail: Mark Aurigemma Telephone: +1 212 600 1960 Portable:+1 646 270 9451 E-mail: In London: Claire Hoffman Phone: +44 20 8892 5215 E-mail: Cathy Bartley Telephone: +44 20 8694 9138 E-mail: In Paris: Michel Aublanc Phone:+33 1 69 286 286 E-mail:.. 3 million now receiving anti-retroviral therapy HIV medications The close of 2007 marks an important step in days gone by history of the HIV/AIDS epidemic.The conference call ID quantity is 6037988. Furthermore, a replay of the meeting call will be available from 11:00 a.m. EDT on Wednesday, April 30, 2014, through 5:00 p.m. EDT on Wednesday, May 7, 2014, and may be accessed at Alkermes' internet site or by dialing +1 888 843 7419 for U.S. Callers and +1 630 652 3042 for international callers. The replay access code is 6037988. About Alkermes plc Alkermes plc is usually a integrated fully, global biopharmaceutical company that applies its scientific knowledge and proprietary technology to develop innovative medications that improve patient outcomes.